Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PTAFR | P25105 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2215031 | 1.00 | PPARG (0.40) | PPARGALDH1A1TSHRLMNATDP1 | |
| SCHEMBL2216976 | 1.00 | PPARG (0.40) | PPARGALDH1A1TSHRLMNATDP1 | |
| SCHEMBL11663818 | 1.00 | PPARG (0.40) | PPARGALDH1A1TSHRLMNATDP1 | |
| SCHEMBL2219048 | 1.00 | PPARG (0.40) | PPARGALDH1A1TSHRLMNATDP1 | |
| SCHEMBL18612429 | 0.94 | MEN1 (0.40) | PPARGTSHRTDP1HCRTR2MEN1 | |
| SCHEMBL12369625 | 0.92 | MEN1 (0.43) | TSHRTDP1HCRTR2MEN1CYP2C19 | |
| SCHEMBL2219973 | 0.92 | SOAT2 (0.37) | PPARGHCRTR2FAAH | |
| SCHEMBL7108821 | 0.88 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL2361796 | 0.88 | MEN1 (0.42) | ALDH1A1TSHRHCRTR2MEN1CYP2C19 | |
| SCHEMBL8974955 | 0.84 | TP53 (0.51) | TSHRMEN1KMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021198725-A1 | FOSALVUDINE AND FOZIVUDINE TIDOXIL FOR USE IN THE TREATMENT OF COVID-19, AND USE OF THE STRUCTURALLY SIMPLIFIED DERIVATIVES THEREOF | CHIRACON GMBH (DE) | 2021-10-07 | — | — | WO | claimed |
| WO-2021198725-A1 | FOSALVUDINE AND FOZIVUDINE TIDOXIL FOR USE IN THE TREATMENT OF COVID-19, AND USE OF THE STRUCTURALLY SIMPLIFIED DERIVATIVES THEREOF | CHIRACON GMBH (DE) | 2021-10-07 | — | — | WO | disclosed |
| US-10758483-B2 | Fluoropolymer emulsions with perhalogenated stabilizer for the delivery of hydrophobic drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2020-09-01 | — | — | US | disclosed |
| US-10426727-B2 | Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-10-01 | — | — | US | disclosed |
| US-20170100336-A1 | Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-04-13 | — | — | US | disclosed |
| US-20170049699-A1 | Fluoropolymer Emulsions with Branched Semifluorinated Block Copolymer or Phospholipid Surfactant for the Delivery of Hydrophobic Drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-02-23 | — | — | US | disclosed |
| WO-2015164781-A1 | FLUOROPOLYMER EMULSIONS WITH BRANCHED SEMIFLUORINATED BLOCK COPOLYMER OR PHOSPHOLIPID SURFACTANT FOR THE DELIVERY OF HYDROPHOBIC DRUGS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-10-29 | — | — | WO | disclosed |
| WO-2015164756-A1 | FLUOROPOLYMER EMULSIONS WITH PERHALOGENATED STABILIZER FOR THE DELIVERY OF HYDROPHOBIC DRUGS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-10-29 | — | — | WO | disclosed |
| EP-0854708-B1 | LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2001-12-12 | — | — | EP | disclosed |
| US-6177469-B1 | ANTIUTOR AGENTS; AUTOIMMUNE DISEASES | HEIDELBERG PHARMA HOLDING GMBH (DE) | 2001-01-23 | — | — | US | disclosed |
| EP-0854708-A1 | LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS | Roche Diagnostics GmbH (DE) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997014410-A1 | LIPID ALCOHOLS AS NEW IMMUNOSUPPRESSIVE AND ANTIVIRAL DRUGS | BOEHRINGER MANNHEIM GMBH (DE) | 1997-04-24 | — | — | WO | disclosed |
| WO-1991005558-A1 | USE OF LECITHIN ANALOGS AS ANTIVIRAL DRUGS AS WELL AS NEW COMPOUNDS | BOEHRINGER MANNHEIM GMBH (DE) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10426727-B2 | Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs | FFAR3, FFAR1, FAU | PPARG 260/4885ALDH1A1 4080/4885TSHR 1016/4885 |
| US-20170049699-A1 | Fluoropolymer Emulsions with Branched Semifluorinated Block Copolymer or Phospholipid Surfactant for the Delivery of Hydrophobic Drugs | FFAR3, FFAR1, FAU | PPARG 260/4885ALDH1A1 4080/4885TSHR 1016/4885 |
| US-10758483-B2 | Fluoropolymer emulsions with perhalogenated stabilizer for the delivery of hydrophobic drugs | PFN1, FFAR1, FAU | PPARG 172/4885ALDH1A1 3013/4885TSHR 1632/4885 |
| US-20170100336-A1 | Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs | PFN1, FFAR1, FAU | PPARG 172/4885ALDH1A1 3013/4885TSHR 1632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.